We bargain bought Ahealth mildly due to its growing market shares and valuation

Apex Healthcare has recently gaining market share in Malaysia pharmaceutical industry.  As of the current down turn, its price has adjusted back to RM 2.50 level compare to a high of around RM 3.3, current PE is around 7-8 times and Forecast year around 6-7 times easily.

I like Tom Peters’ theory, if i am not remember wrongly.  “Management by walking around”  That also a key factor to always give boost to us if we confident to see that Apex’s products have been growing seen in many clinics.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Blog at WordPress.com.

Up ↑

%d bloggers like this: